Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Gynecomastia: incidence, causes and treatment.

Deepinder F, Braunstein GD.

Expert Rev Endocrinol Metab. 2011 Sep;6(5):723-730. doi: 10.1586/eem.11.57.

PMID:
30780874
2.

Pharmacogenetic profile and major depressive and/or bipolar disorder treatment: a retrospective, cross-sectional study.

Tonozzi TR, Braunstein GD, Kammesheidt A, Curran C, Golshan S, Kelsoe J.

Pharmacogenomics. 2018 Oct;19(15):1169-1179. doi: 10.2217/pgs-2018-0088. Epub 2018 Sep 12.

3.

Mutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer.

Kammesheidt A, Tonozzi TR, Lim SW, Braunstein GD.

Int J Mol Epidemiol Genet. 2018 Feb 5;9(1):1-12. eCollection 2018.

4.

IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?

Lupo M, Guttler R, Geck Z, Tonozzi TR, Kammesheidt A, Braunstein GD.

Endocr Pract. 2018 May;24(5):453-459. doi: 10.4158/EP-2017-0213. Epub 2018 Mar 2.

PMID:
29498908
5.

Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic pain.

Morlock R, Braunstein GD.

Pain Rep. 2017 Aug 11;2(5):e615. doi: 10.1097/PR9.0000000000000615. eCollection 2017 Sep.

6.

Systems Addressing Frail Elder Care: Description of a Successful Model.

Ansryan LZ, Aronow HU, Borenstein JE, Mena V, Haus F, Palmer K, Chan E, Swanson JW, Mass S, Rosen B, Braunstein GD, Burnes Bolton L.

J Nurs Adm. 2018 Jan;48(1):11-17. doi: 10.1097/NNA.0000000000000564. Review.

PMID:
29219905
7.

Tumor-associated DNA mutation detection in individuals undergoing colonoscopy.

Fleshner P, Braunstein GD, Ovsepyan G, Tonozzi TR, Kammesheidt A.

Cancer Med. 2018 Jan;7(1):167-174. doi: 10.1002/cam4.1249. Epub 2017 Nov 10.

9.

Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).

Thurston RC, Johnson BD, Shufelt CL, Braunstein GD, Berga SL, Stanczyk FZ, Pepine CJ, Bittner V, Reis SE, Thompson DV, Kelsey SF, Sopko G, Bairey Merz CN.

Menopause. 2017 Feb;24(2):126-132. doi: 10.1097/GME.0000000000000731.

10.

Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.

Sacks WL, Bose S, Zumsteg ZS, Wong R, Shiao SL, Braunstein GD, Ho AS.

Cancer Cytopathol. 2016 Oct;124(10):722-728. doi: 10.1002/cncy.21749. Epub 2016 Jun 27.

11.

Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.

Merz CN, Shaw LJ, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-DeHoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ.

J Womens Health (Larchmt). 2016 Sep;25(9):875-81. doi: 10.1089/jwh.2015.5441. Epub 2016 Jun 6.

12.

Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement.

Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV.

J Clin Endocrinol Metab. 2016 Apr;101(4):1318-43. doi: 10.1210/jc.2016-1271. Review.

PMID:
27032319
13.

Identification and team-based interprofessional management of hospitalized vulnerable older adults.

Borenstein JE, Aronow HU, Bolton LB, Dimalanta MI, Chan E, Palmer K, Zhang X, Rosen B, Braunstein GD.

Nurs Outlook. 2016 Mar-Apr;64(2):137-145. doi: 10.1016/j.outlook.2015.11.014. Epub 2015 Nov 22.

14.

Black adrenal adenoma causing Cushing's syndrome: 40 years ago and today.

Yu R, Wei M, Fan X, Ellis RR, Braunstein GD.

Endocrinol Nutr. 2015 Nov;62(9):466-9. doi: 10.1016/j.endonu.2015.05.002. Epub 2015 Jun 15. No abstract available.

PMID:
26088906
15.

Recognizing Sex Similarities in Cardiovascular Disease Research.

Shufelt C, Braunstein GD, Pepine CJ, Bairey Merz CN.

J Am Coll Cardiol. 2015 May 19;65(19):2152-3. doi: 10.1016/j.jacc.2015.02.066. No abstract available.

16.

Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations.

Lodish MB, Yuan B, Levy I, Braunstein GD, Lyssikatos C, Salpea P, Szarek E, Karageorgiadis AS, Belyavskaya E, Raygada M, Faucz FR, Izzat L, Brain C, Gardner J, Quezado M, Carney JA, Lupski JR, Stratakis CA.

Eur J Endocrinol. 2015 Jun;172(6):803-11. doi: 10.1530/EJE-14-1154.

17.

Clinically meaningful end points in the evolving treatment paradigm for radioactive iodine-refractory differentiated thyroid cancer.

Sacks W, Braunstein GD.

Expert Rev Endocrinol Metab. 2015 May;10(3):337-344. doi: 10.1586/17446651.2015.1020299. Epub 2015 Mar 3.

PMID:
30298771
18.

Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.

Sacks W, Wong RM, Bresee C, Braunstein GD.

Thyroid. 2015 Apr;25(4):377-85. doi: 10.1089/thy.2014.0298. Epub 2015 Feb 6.

PMID:
25578116
19.

Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.

Garg M, Okamoto R, Nagata Y, Kanojia D, Venkatesan S, M T A, Braunstein GD, Said JW, Doan NB, Ho Q, Akagi T, Gery S, Liu LZ, Tan KT, Chng WJ, Yang H, Ogawa S, Koeffler HP.

J Clin Endocrinol Metab. 2015 Feb;100(2):725-35. doi: 10.1210/jc.2014-2359. Epub 2014 Nov 3.

20.

Validating SPICES as a Screening Tool for Frailty Risks among Hospitalized Older Adults.

Aronow HU, Borenstein J, Haus F, Braunstein GD, Bolton LB.

Nurs Res Pract. 2014;2014:846759. doi: 10.1155/2014/846759. Epub 2014 Apr 27.

21.

Off-target effects of c-MET inhibitors on thyroid cancer cells.

Zhou Y, Zhao C, Gery S, Braunstein GD, Okamoto R, Alvarez R, Miles SA, Doan NB, Said JW, Gu J, Phillip Koeffler H.

Mol Cancer Ther. 2014 Jan;13(1):134-43. doi: 10.1158/1535-7163.MCT-13-0187. Epub 2013 Oct 29.

22.

Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.

Garg M, Kanojia D, Okamoto R, Jain S, Madan V, Chien W, Sampath A, Ding LW, Xuan M, Said JW, Doan NB, Liu LZ, Yang H, Gery S, Braunstein GD, Koeffler HP.

J Clin Endocrinol Metab. 2014 Jan;99(1):E62-72. doi: 10.1210/jc.2013-2994. Epub 2013 Dec 20.

23.

Evolving approaches in managing radioactive iodine-refractory differentiated thyroid cancer.

Sacks W, Braunstein GD.

Endocr Pract. 2014 Mar;20(3):263-75. doi: 10.4158/EP13305.RA. Review.

PMID:
24126232
24.

Global clinical response in Cushing's syndrome patients treated with mifepristone.

Katznelson L, Loriaux DL, Feldman D, Braunstein GD, Schteingart DE, Gross C.

Clin Endocrinol (Oxf). 2014 Apr;80(4):562-9. doi: 10.1111/cen.12332. Epub 2013 Oct 17.

25.

The long gestation of the modern home pregnancy test.

Braunstein GD.

Clin Chem. 2014 Jan;60(1):18-21. doi: 10.1373/clinchem.2013.202655. Epub 2013 Sep 11. No abstract available.

26.

Early recognition of risk factors for adverse outcomes during hospitalization among Medicare patients: a prospective cohort study.

Borenstein J, Aronow HU, Bolton LB, Choi J, Bresee C, Braunstein GD.

BMC Geriatr. 2013 Jul 8;13:72. doi: 10.1186/1471-2318-13-72.

27.

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer.

Chan D, Zheng Y, Tyner JW, Chng WJ, Chien WW, Gery S, Leong G, Braunstein GD, Koeffler HP.

J Cancer Res Clin Oncol. 2013 Sep;139(9):1507-14. doi: 10.1007/s00432-013-1465-6. Epub 2013 Jul 4.

28.

A quality improvement intervention to reduce the rate of elective deliveries < 39 weeks.

El Haj Ibrahim S, Gregory KD, Kilpatrick SJ, Braunstein GD.

Jt Comm J Qual Patient Saf. 2013 Jun;39(6):274-8. No abstract available.

PMID:
23789166
29.

Clinical and professional ethics guidelines for the practice of thyroidology.

Rosenthal MS, Angelos P, Cooper DS, Fassler C, Finder SG, Hays MT, Tendler B, Braunstein GD; American Thyroid Association Ethics Advisory Committee.

Thyroid. 2013 Oct;23(10):1203-10. doi: 10.1089/thy.2013.0124. Epub 2013 Sep 14. No abstract available.

PMID:
23750916
30.

Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.

Wong RM, Bresee C, Braunstein GD.

Thyroid. 2013 May;23(5):566-74. doi: 10.1089/thy.2012.0181.

PMID:
23106409
31.

Drug-induced gynecomastia: an evidence-based review.

Deepinder F, Braunstein GD.

Expert Opin Drug Saf. 2012 Sep;11(5):779-95. doi: 10.1517/14740338.2012.712109. Epub 2012 Aug 6. Review.

PMID:
22862307
32.

Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo.

Chan D, Tyner JW, Chng WJ, Bi C, Okamoto R, Said J, Ngan BD, Braunstein GD, Koeffler HP.

Oncol Lett. 2012 Apr 1;3(4):807-815. Epub 2012 Jan 20.

33.

Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Davis SR, Braunstein GD.

J Sex Med. 2012 Apr;9(4):1134-48. doi: 10.1111/j.1743-6109.2011.02634.x. Epub 2012 Feb 3. Review.

PMID:
22304681
34.

Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study.

Shufelt C, Merz CN, Yang Y, Kirschner J, Polk D, Stanczyk F, Paul-Labrador M, Braunstein GD.

J Womens Health (Larchmt). 2012 Mar;21(3):281-4. doi: 10.1089/jwh.2011.3001. Epub 2011 Dec 7.

35.

Do patients gain weight after thyroidectomy for thyroid cancer?

Weinreb JT, Yang Y, Braunstein GD.

Thyroid. 2011 Dec;21(12):1339-42. doi: 10.1089/thy.2010.0393. Epub 2011 Nov 8.

PMID:
22066475
36.

A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause.

Painovich JM, Shufelt CL, Azziz R, Yang Y, Goodarzi MO, Braunstein GD, Karlan BY, Stewart PM, Merz CN.

Menopause. 2012 Jan;19(1):54-61. doi: 10.1097/gme.0b013e31821f9171.

37.

Testosterone reference ranges in normally cycling healthy premenopausal women.

Braunstein GD, Reitz RE, Buch A, Schnell D, Caulfield MP.

J Sex Med. 2011 Oct;8(10):2924-34. doi: 10.1111/j.1743-6109.2011.02380.x. Epub 2011 Jul 19.

PMID:
21771278
38.

Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

Shufelt CL, Johnson BD, Berga SL, Braunstein GD, Reis SE, Bittner V, Yang Y, Pepine CJ, Sharaf BL, Sopko G, Kelsey SF, Merz CN; Women's Ischemia Syndrome Evaluation Study Group.

Menopause. 2011 Sep;18(9):943-50. doi: 10.1097/gme.0b013e3182113672.

39.

Update on subclinical hyperthyroidism.

Donangelo I, Braunstein GD.

Am Fam Physician. 2011 Apr 15;83(8):933-8. Review.

40.

Unusual case of multiple endocrine neoplasia type 2A syndrome without medullary thyroid carcinoma.

Tyer NM, Braunstein GD, Frishberg D.

Endocr Pract. 2011 Mar-Apr;17(2):e4-7. doi: 10.4158/EP10157.CR.

PMID:
21134882
41.

The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.

Sacks W, Fung CH, Chang JT, Waxman A, Braunstein GD.

Thyroid. 2010 Nov;20(11):1235-45. doi: 10.1089/thy.2009.0455. Review.

PMID:
21062195
42.

Do faculty intensivists have better outcomes when caring for patients directly in a closed ICU versus consulting in an open ICU?

Hackner D, Shufelt CL, Balfe DD, Lewis MI, Elsayegh A, Braunstein GD, Mosenifar Z.

Hosp Pract (1995). 2009 Dec;37(1):40-50. doi: 10.3810/hp.2009.12.253.

PMID:
20877170
43.

Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors.

Harvey RA, Mitchell HD, Stenman UH, Blankenstein MA, Nustad K, Stieber P, Stewart W, Savage PM, Seckl MJ, Braunstein GD.

J Reprod Med. 2010 Jul-Aug;55(7-8):285-95.

PMID:
20795340
44.

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Shufelt C, Bretsky P, Almeida CM, Johnson BD, Shaw LJ, Azziz R, Braunstein GD, Pepine CJ, Bittner V, Vido DA, Stanczyk FZ, Bairey Merz CN.

J Clin Endocrinol Metab. 2010 Nov;95(11):4985-92. doi: 10.1210/jc.2010-0143. Epub 2010 Aug 25.

45.

The presentation of hypoactive sexual desire disorder in premenopausal women.

Maserejian NN, Shifren JL, Parish SJ, Braunstein GD, Gerstenberger EP, Rosen RC.

J Sex Med. 2010 Oct;7(10):3439-48. doi: 10.1111/j.1743-6109.2010.01934.x.

PMID:
20646184
46.

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH; Endocrine Society.

J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. doi: 10.1210/jc.2009-2509. Epub 2010 Jun 21. Review.

47.

The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.

Johnson BD, Dwyer KM, Stanczyk FZ, Bittner V, Berga SL, Braunstein GD, Azziz R, Yang Y, Hale GE, Bairey Merz CN.

J Clin Endocrinol Metab. 2010 Sep;95(9):4432-40. doi: 10.1210/jc.2010-0126. Epub 2010 Jun 16.

48.

Androgen deficiency and therapy in women.

Mathur R, Braunstein GD.

Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):342-9. doi: 10.1097/MED.0b013e32833ab083. Review.

PMID:
20489611
49.

Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question.

Bairey Merz CN, Shufelt C, Johnson BD, Azziz R, Braunstein GD.

Maturitas. 2010 Apr;65(4):297-8. doi: 10.1016/j.maturitas.2010.01.003. Epub 2010 Jan 22. No abstract available.

50.

Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Merz CN, Johnson BD, Berga SL, Braunstein GD, Azziz R, Yang Y, Reis SE, Bittner V, Hodgson TK, Pepine CJ, Sharaf BL, Sopko G, Kelsey SF; Women's Ischemia Syndrome Evaluation Study Group.

J Womens Health (Larchmt). 2009 Sep;18(9):1315-22. doi: 10.1089/jwh.2008.1063.

Supplemental Content

Loading ...
Support Center